ANI Pharmaceuticals | ANIP

Stock Price
95.35
Daily Change
-0.65 -0.68%
Monthly
38.01%
Yearly
57.58%
Q3 Forecast
94.56

Peers Price Chg Day Year Date
AbbVie 212.56 -0.44 -0.21% 9.95% Sep/05
Aurora Cannabis 6.78 0.09 1.35% -7.50% Sep/05
ANI Pharmaceuticals 95.35 -0.65 -0.68% 57.58% Sep/05
Knight Therapeutics 6.44 0 0% 14.18% Sep/05
Hikma Pharmaceutical 1,720.00 -3.00 -0.17% -12.07% Sep/05
Eli Lilly 727.21 -15.70 -2.11% -19.48% Sep/05
Novartis 129.82 1.34 1.04% 11.22% Sep/05
Perrigo 23.49 -0.25 -1.05% -19.14% Sep/02
Sun Pharmaceuticals 1,593.60 11.30 0.71% -12.66% Sep/05
Teva Pharmaceutical Industries 6,275.00 -65.00 -1.03% -9.12% Sep/04
Canopy Growth 2.02 0.11 5.76% -66.72% Sep/05

Indexes Price Day Year Date
USND 21700 -7.31 -0.03% 30.01% Sep/05
US2000 2391 11.44 0.48% 14.33% Sep/05

ANI Pharmaceuticals traded at $95.35 this Friday September 5th, decreasing $0.65 or 0.68 percent since the previous trading session. Looking back, over the last four weeks, ANI Pharmaceuticals lost 38.01 percent. Over the last 12 months, its price rose by 57.58 percent. Looking ahead, we forecast ANI Pharmaceuticals to be priced at 94.56 by the end of this quarter and at 92.22 in one year, according to Trading Economics global macro models projections and analysts expectations.

ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company. The Company is focused on developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. The Company focuses on areas, including controlled substances, oncology products (anti-cancer), hormones and steroids, and complex formulations. Its products include Aminocaproic Acid Tablets USP, ApexiCon E (diflorasone diacetate cream USP (emollient)), Arimidex (anastrozole) tablets, Atacand HCT (candesartan cilexetil - hydrochlorothiazide) Tablets, Atacand (candesartan cilexetil) Tablets, Bexarotene Capsules, Bicalutamide Tablets USP, and more. Its branded products include Cortenema, Cortrophin gel, Cortrophin-Zinc, Inderal LA, Inderal XL, InnoPran XL, Lithobid, Reglan, and Vancocin. It operates across three pharmaceutical manufacturing facilities, of which two are located in Baudette, Minnesota and one is located in Oakville, Ontario.